SIGNAL-DRIVEN SALES

Turn Funding Signals into Pipeline

Fundz analyzes real-time funding events through YOUR lens to surface companies most likely to buy — with the “why now” built in.

10–25 ICP-matched leads daily • Buyer-intent scoring • No duplicates

Every plan includes:

✓Signal-Driven Leads Based on YOUR ICP

✓Slack + Chrome real-time alerts

✓No duplicates — only new events

INDUSTRY FIRST

Moleculight Secures Financing From Bdc Canada And Igan Partners To Support Its Commercial Expansion

Aug 11, 2022•about 3 years ago

TorontoBiotechnologyHealth Care

Description

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DXTM devices. Leonard Kofman and Jody Staggs, Managing Director of SWK Holdings will join MolecuLight's Board of Directors as observers.

Company Information

Company

MolecuLight

Location

425 University Ave, Suite 700

Toronto, Ontario, Canada

About

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

Company News

(7 articles)

Mon, 06 Jan 2025 08:00:00 GMT

MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor - PR Newswire

Thu, 04 Sep 2025 12:00:00 GMT

MolecuLight Showcases 10 Scientific Posters at SAWC Fall and Announces Upcoming Oxygenation Imaging on the MolecuLightDX®+ Platform - PR Newswire UK

Thu, 06 Jul 2023 07:00:00 GMT

Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors - PR Newswire

Mon, 18 Dec 2017 08:00:00 GMT

Handheld device reveals bacteria in wounds - New Atlas

Thu, 24 Jan 2019 08:00:00 GMT

MolecuLight camera can see bacteria invisible to human eye - WKYC

Thu, 10 Jul 2025 07:00:00 GMT

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption - PR Newswire

Tue, 28 Jan 2025 08:00:00 GMT

MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive Plastic Surgery by Dr. Michael Desvigne at the 47th Annual JAB Maui Burn & Wound Symposium - Adnkronos

FundzWatch™ Score

Medium Activity